Insider Transactions in Q2 2021 at Senseonics Holdings, Inc. (SENS)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 15
2021
|
Timothy T Goodnow President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
66,449
-1.36%
|
$199,347
$3.69 P/Share
|
|
Jun 15
2021
|
Francine Kaufman Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
11,499
-0.99%
|
$34,497
$3.69 P/Share
|
|
Jun 15
2021
|
Kenneth L Horton GC & Corp. Development Advisor |
SELL
Payment of exercise price or tax liability
|
Direct |
10,899
-0.94%
|
$32,697
$3.69 P/Share
|
|
Jun 15
2021
|
Mirasol Panlilio VP Global Sales and Marketing |
SELL
Payment of exercise price or tax liability
|
Direct |
8,602
-0.83%
|
$25,806
$3.69 P/Share
|
|
Jun 15
2021
|
Nick B. Tressler Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,850
-3.48%
|
$23,550
$3.69 P/Share
|
|
Jun 15
2021
|
Mukul Jain Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
20,212
-1.03%
|
$60,636
$3.69 P/Share
|
|
Jun 14
2021
|
Mukul Jain Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
50,000
-2.47%
|
$200,000
$4.36 P/Share
|
|
Jun 14
2021
|
Mukul Jain Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+2.41%
|
$0
$0.54 P/Share
|
|
Jun 14
2021
|
Timothy T Goodnow President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
27,928
+0.57%
|
$27,928
$1.79 P/Share
|
|
Jun 11
2021
|
Francine Kaufman Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
62,628
-5.59%
|
$250,512
$4.0 P/Share
|
|
Jun 11
2021
|
Francine Kaufman Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,916
+1.83%
|
$62,748
$3.07 P/Share
|
|
Jun 10
2021
|
Timothy T Goodnow President and CEO |
SELL
Open market or private sale
|
Direct |
380,710
-7.31%
|
$1,142,130
$3.6 P/Share
|
|
Jun 10
2021
|
Timothy T Goodnow President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
380,710
+6.81%
|
$0
$0.54 P/Share
|
|
Jun 10
2021
|
Mukul Jain Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
18,866
-0.95%
|
$56,598
$3.51 P/Share
|
|
Jun 10
2021
|
Mukul Jain Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
18,866
+0.94%
|
$0
$0.54 P/Share
|
|
Jun 09
2021
|
Mukul Jain Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
6,134
-0.31%
|
$18,402
$3.5 P/Share
|
|
Jun 09
2021
|
Mukul Jain Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,134
+0.31%
|
$0
$0.54 P/Share
|
|
Jun 04
2021
|
Mukul Jain Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
25,000
-1.25%
|
$50,000
$2.7 P/Share
|
|
Jun 04
2021
|
Mukul Jain Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+1.24%
|
$0
$0.54 P/Share
|
|
Jun 04
2021
|
Francine Kaufman Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
62,627
-5.39%
|
$187,881
$3.0 P/Share
|
|
May 27
2021
|
Stephen P De Falco |
SELL
Open market or private sale
|
Direct |
104,927
-8.23%
|
$209,854
$2.0 P/Share
|
|
May 26
2021
|
Stephen P De Falco |
SELL
Open market or private sale
|
Direct |
4,304
-0.34%
|
$8,608
$2.0 P/Share
|
|
May 25
2021
|
Anthony R. Raab |
BUY
Grant, award, or other acquisition
|
Direct |
60,483
+14.61%
|
-
|
|
May 25
2021
|
Douglas A Roeder |
BUY
Grant, award, or other acquisition
|
Direct |
60,483
+24.56%
|
-
|
|
May 25
2021
|
Douglas A Roeder |
SELL
Open market or private sale
|
Direct |
147,735
-54.1%
|
$147,735
$1.91 P/Share
|
|
May 25
2021
|
Stephen P De Falco |
BUY
Grant, award, or other acquisition
|
Direct |
60,483
+4.52%
|
-
|
|
May 25
2021
|
Edelman Steven |
BUY
Grant, award, or other acquisition
|
Direct |
60,483
+13.71%
|
-
|
|
May 25
2021
|
Edelman Steven |
SELL
Open market or private sale
|
Direct |
109,231
-25.45%
|
$109,231
$1.91 P/Share
|
|
May 25
2021
|
Edward Fiorentino |
BUY
Grant, award, or other acquisition
|
Direct |
60,483
+13.3%
|
-
|
|
May 25
2021
|
Edward Fiorentino |
SELL
Open market or private sale
|
Direct |
109,231
-24.66%
|
$109,231
$1.91 P/Share
|
|
May 25
2021
|
Douglas S Prince |
BUY
Grant, award, or other acquisition
|
Direct |
60,483
+17.15%
|
-
|
|
May 25
2021
|
Douglas S Prince |
SELL
Open market or private sale
|
Direct |
136,539
-37.07%
|
$136,539
$1.9 P/Share
|
|
May 25
2021
|
Nick B. Tressler Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
215,053
+50.0%
|
-
|
|
May 25
2021
|
Kenneth L Horton GC & Corp. Development Advisor |
BUY
Grant, award, or other acquisition
|
Direct |
306,451
+20.86%
|
-
|
|
May 25
2021
|
Timothy T Goodnow President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
1,099,462
+18.54%
|
-
|
|
May 25
2021
|
Mukul Jain Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
403,225
+17.09%
|
-
|
|
May 25
2021
|
Francine Kaufman Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
273,118
+19.03%
|
-
|
|
May 25
2021
|
Mirasol Panlilio VP Global Sales and Marketing |
BUY
Grant, award, or other acquisition
|
Direct |
204,301
+16.94%
|
-
|
|
May 19
2021
|
Douglas A Roeder |
SELL
Open market or private sale
|
Indirect |
652
-100.0%
|
$1,304
$2.08 P/Share
|
|
May 17
2021
|
Mukul Jain Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
100,000
-5.48%
|
$100,000
$1.94 P/Share
|
|
May 15
2021
|
Kenneth L Horton GC & Corp. Development Advisor |
SELL
Payment of exercise price or tax liability
|
Direct |
34,710
-3.9%
|
$34,710
$1.92 P/Share
|
|
May 15
2021
|
Timothy T Goodnow President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
231,007
-5.83%
|
$231,007
$1.92 P/Share
|
|
May 15
2021
|
Mukul Jain Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
94,433
-5.73%
|
$94,433
$1.92 P/Share
|
|
May 15
2021
|
Francine Kaufman Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
44,056
-4.72%
|
$44,056
$1.92 P/Share
|
|
May 15
2021
|
Mirasol Panlilio VP Global Sales and Marketing |
SELL
Payment of exercise price or tax liability
|
Direct |
39,351
-4.7%
|
$39,351
$1.92 P/Share
|
|
Apr 12
2021
|
Douglas A Roeder |
SELL
Open market or private sale
|
Indirect |
4,953,906
-99.32%
|
$9,907,812
$2.12 P/Share
|
|
Apr 09
2021
|
Douglas A Roeder |
SELL
Open market or private sale
|
Indirect |
4,892,388
-49.67%
|
$9,784,776
$2.39 P/Share
|
|
Apr 01
2021
|
Douglas S Prince |
BUY
Grant, award, or other acquisition
|
Direct |
2,919
+0.79%
|
$5,838
$2.58 P/Share
|
|
Apr 01
2021
|
Peter Justin Klein Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,470
+0.66%
|
$4,940
$2.58 P/Share
|
|
Apr 01
2021
|
Edward Fiorentino |
BUY
Grant, award, or other acquisition
|
Direct |
4,941
+1.1%
|
$9,882
$2.58 P/Share
|